EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer

Thalita Bueno Corrêa, Gabriel Lucas da Fonseca, Rauni Borges Marques, Sandro Mascena Gomes-Filho, Lutero Augusto Hasenkamp, Yuli Thamires Magalhães, Lillian Cristina Russo Vieira iD, Nicolas Paulino Rezende, Stefany Cristine Rodrigues da Silva, Nicolas Carlos Hoch iD, Fabio Luis Forti iD, Elena Levantini iD und 2 weitere

IUBMB Life · 2026-11 · 78 (11)

DOI: 10.1002/iub.70140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, online erschienen am 09.11.2026. Verfasst von Thalita Bueno Corrêa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Chemistry Institute, São Paulo University, São Paulo, Brazil. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Drug Resistance, Neoplasm, RNA, Long Noncoding, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation (FAPESP), National Council for Scientific and Technological Development (CNPq), Associazione Italiana per la Ricerca sul Cancro (AIRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncogenic KRAS mutations are the primary drivers of pancreatic ductal adenocarcinoma (PDAC), but the noncoding landscape downstream of KRAS remains to be fully elucidated. Here, by integrating PDAC RNA sequencing and exome data from The Cancer Genome Atlas (TCGA), we identified 49 long intergenic noncoding RNAs (lincRNAs) differentially expressed according to KRAS mutation status. Among these, LINC00941 emerged as a primary candidate, as its expression is regulated by KRAS in both loss‐ and gain‐of‐function models and is significantly upregulated in PDAC tumors. Analysis of single‐cell RNA sequencing and clinical datasets (TCGA/ICGC) revealed that LINC00941 is significantly enriched in PDAC malignant epithelial cells and correlates with poor PDAC patient prognosis. Functional assays demonstrated that LINC00941 knockdown impairs PDAC cell migration and invasion. Notably, LINC00941‐depleted cells exhibit delayed DNA repair following irradiation, as shown by the slower resolution of radiation‐induced DNA strand breaks, and increased sensitivity to gemcitabine‐induced apoptosis. Transcriptomic and RT‐qPCR analyses associated the loss of LINC00941 with a significant reduction in key DNA repair and survival‐related genes, including BACH1, TOP2A, and BIRC5. These findings suggest that LINC00941 is required to maintain genomic stability and promote survival under therapeutic stress in KRAS‐driven cells. In conclusion, our study identifies a novel KRAS/LINC00941 axis that supports a pro‐survival and chemoresistant phenotype in PDAC, positioning LINC00941 as a mediator of the DNA damage response and a potential therapeutic target in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsDrug Resistance, NeoplasmRNA, Long NoncodingProto-Oncogene Proteins p21(ras)DNA RepairCarcinoma, Pancreatic DuctalBiomarkers, TumorHumansGene Expression Regulation, NeoplasticSignal TransductionDeoxycytidineCell Line, TumorGemcitabineCell MovementApoptosisPrognosisMutationCell Proliferation

Stichwörter der Autor:innen

DNA repairKRASchemoresistancelong noncoding RNApancreatic cancer

Substanzen

RNA, Long NoncodingProto-Oncogene Proteins p21(ras)KRAS protein, humanDeoxycytidineGemcitabineBiomarkers, Tumor

Autor:innen und Institutionen

  • Biochemistry Department, Chemistry Institute, São Paulo University, São Paulo, Brazil.
  • Interunit Graduate Program in Bioinformatics, University of São Paulo, São Paulo, Brazil.
  • Institute of Biomedical Technologies, National Research Council (CNR), Pisa, Italy.

ORCID-Profile: Lillian Cristina Russo Vieira, Nicolas Carlos Hoch, Fabio Luis Forti, Elena Levantini, Eduardo Moraes Reis, Daniela Sanchez Bassères

Förderung

  • São Paulo Research Foundation (FAPESP)
  • National Council for Scientific and Technological Development (CNPq)
  • Associazione Italiana per la Ricerca sul Cancro (AIRC)
  • Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Corrêa, T. B., da Fonseca, G. L., Marques, R. B., Gomes-Filho, S. M., Hasenkamp, L. A., Magalhães, Y. T., Vieira, L. C. R., Rezende, N. P., da Silva, S. C. R., Hoch, N. C., Forti, F. L., Levantini, E., Reis, E. M., & Bassères, D. S. (2026). Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer. IUBMB Life, 78(11). https://doi.org/10.1002/iub.70140

Vancouver

Corrêa TB, da Fonseca GL, Marques RB, Gomes-Filho SM, Hasenkamp LA, Magalhães YT, et al. Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer. IUBMB Life. 2026;78(11). doi:10.1002/iub.70140

BibTeX
@article{Corra2026,
  author = {Corrêa, Thalita Bueno and da Fonseca, Gabriel Lucas and Marques, Rauni Borges and Gomes-Filho, Sandro Mascena and Hasenkamp, Lutero Augusto and Magalhães, Yuli Thamires and Vieira, Lillian Cristina Russo and Rezende, Nicolas Paulino and da Silva, Stefany Cristine Rodrigues and Hoch, Nicolas Carlos and Forti, Fabio Luis and Levantini, Elena and Reis, Eduardo Moraes and Bassères, Daniela Sanchez},
  title = {Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer},
  journal = {IUBMB Life},
  year = {2026},
  volume = {78},
  number = {11},
  doi = {10.1002/iub.70140}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche